Antiinflammatory actions of glucagon-like peptide-1based therapies beyond metabolic benefits Text PDF Abstract Therapies based on glucagon-like peptide-1 (GLP-1) reduce rates of cardiovascular and chronic kidney disease in people with type 2 diabetes and/or obesity, with ongoing clinical trials investigating their effects in people with metabolic liver disease, arthritis, and both substance use and neurodegenerative disorders
Shilajit is revered in traditional medicine for its rejuvenating properties, including its potential to support brain health
Excited to share that the final chapter of my PhD thesis is now published in the Journal of Medicinal Chemistry ( Although reactivity with glutathione is commonly used as a proxy for metabolic liability of covalent drugs, in this work we show that the intrinsic reactivity (electrophilicity) of covalent warheads is not a reliable predictor of their in vivo metabolic susceptibility
Patients with established hypertension and obesity represent a particularly relevant population, as weight reduction can substantially improve blood pressure control and potentially reduce medication burden
Most patients find that the gastrointestinal effects are mild to moderate and become more manageable over time
Ipamorelin is a five residue synthetic secretagogue peptide
